Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
Rosa Maria Vitale, Fabio Arturo Iannotti, Pietro Amodeo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4876-4876
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

The therapeutic potential of purified cannabidiol
Saoirse E. O′Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t
Catalina Christensen, Martin Rose, Claus Cornett, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 25
Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPARγ
Fernanda da Silva Rodrigues, William Robert Newton, Isadora D’Ávila Tassinari, et al.
Neurochemistry International (2024) Vol. 177, pp. 105769-105769
Open Access | Times Cited: 11
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model
Elisa Landucci, Costanza Mazzantini, Daniele Lana, et al.
Neurobiology of Disease (2022) Vol. 174, pp. 105895-105895
Open Access | Times Cited: 36
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
Cannabis-Related Disorders and Toxic Effects
David A. Gorelick
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2267-2275
Closed Access | Times Cited: 16
Mitofusin 2 confers the suppression of microglial activation by cannabidiol: Insights from in vitro and in vivo models
Mengfan Li, Bingtian Xu, Xing Li, et al.
Brain Behavior and Immunity (2022) Vol. 104, pp. 155-170
Closed Access | Times Cited: 23
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
Débora Cristina Niero Fabris, Milene Cristina de Carvalho, Marcus Lira Brandão, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 12, pp. 1371-1383
Open Access | Times Cited: 22
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Claire Alexander, Jiyoon Jeon, Kyle Nickerson, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116742-116742
Closed Access
The Impact of a Quinone Scaffold on Thermo-TRPs Modulation by Dimethylheptyl Phytocannabinoids
Aniello Schiano Moriello, Aurora Bossoni, Daiana Mattoteia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2682-2682
Open Access
THC, CBD and minor cannabinoid CBDV differently modulate hippocampal neurons firing
Giulia Tomagra, Nikita Gandlevskiy, Elena Rosso, et al.
NeuroToxicology (2025) Vol. 108, pp. 180-190
Closed Access
Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol
Gabriela Pandini Silote, Michelle Carvalho Gatto, Amanda Eskelund, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1269-1269
Open Access | Times Cited: 28
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes
Dmytro Isaev, Waheed Shabbir, Ege Y. Dinc, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
An Overview of Cannabidiol
Alexandra Sideris, Lisa Doan
Anesthesia & Analgesia (2023) Vol. 138, Iss. 1, pp. 54-68
Open Access | Times Cited: 9
Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review
Tristan Hurzeler, Joshua Watt, Warren Logge, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders
Fabio Arturo Iannotti
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 238-238
Open Access | Times Cited: 8
In Vitro Studies on Therapeutic Effects of Cannabidiol in Neural Cells: Neurons, Glia, and Neural Stem Cells
Kim Jungnam, Hyunwoo Choi, Eunhye Kang, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 6077-6077
Open Access | Times Cited: 19
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments
Hugo Bayer, Cristina Aparecida Jark Stern, Fernanda Troyner, et al.
Neuropharmacology (2021) Vol. 205, pp. 108913-108913
Closed Access | Times Cited: 18
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence
Ricardo J. Rodrigues, Joana M. Marques, Attila Köfalvi
Cells (2024) Vol. 13, Iss. 22, pp. 1875-1875
Open Access | Times Cited: 2
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol
Elisa Landucci, Costanza Mazzantini, Daniele Lana, et al.
Toxics (2022) Vol. 10, Iss. 2, pp. 48-48
Open Access | Times Cited: 12
Dravet Syndrome as an Example of Precision Medicine in Epilepsy
Joseph Sullivan, Elaine Wirrell
Epiliepsy currents/Epilepsy currents (2022) Vol. 23, Iss. 1, pp. 4-7
Open Access | Times Cited: 10
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
Baoyu Shen, Dongxian Zhang, Xiaofeng Zeng, et al.
Psychopharmacology (2022) Vol. 239, Iss. 5, pp. 1521-1537
Closed Access | Times Cited: 9
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115109-115109
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top